BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

695 related articles for article (PubMed ID: 15197101)

  • 1. Neuroprotective efficacy and therapeutic time window of peroxynitrite decomposition catalysts in focal cerebral ischemia in rats.
    Thiyagarajan M; Kaul CL; Sharma SS
    Br J Pharmacol; 2004 Jul; 142(5):899-911. PubMed ID: 15197101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotective effects of NU1025, a PARP inhibitor in cerebral ischemia are mediated through reduction in NAD depletion and DNA fragmentation.
    Kaundal RK; Shah KK; Sharma SS
    Life Sci; 2006 Nov; 79(24):2293-302. PubMed ID: 16935310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective effects of an alkaloid-free ethyl acetate extract from the root of Sophora flavescens Ait. against focal cerebral ischemia in rats.
    Park SJ; Nam KW; Lee HJ; Cho EY; Koo U; Mar W
    Phytomedicine; 2009 Nov; 16(11):1042-51. PubMed ID: 19427179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective effect of 4-amino-1,8-napthalimide, a poly(ADP ribose) polymerase inhibitor in middle cerebral artery occlusion-induced focal cerebral ischemia in rat.
    Kabra DG; Thiyagarajan M; Kaul CL; Sharma SS
    Brain Res Bull; 2004 Feb; 62(5):425-33. PubMed ID: 15168908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amelioration of neurological and biochemical deficits by peroxynitrite decomposition catalysts in experimental diabetic neuropathy.
    Arora M; Kumar A; Kaundal RK; Sharma SS
    Eur J Pharmacol; 2008 Oct; 596(1-3):77-83. PubMed ID: 18768138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baicalin can scavenge peroxynitrite and ameliorate endogenous peroxynitrite-mediated neurotoxicity in cerebral ischemia-reperfusion injury.
    Xu M; Chen X; Gu Y; Peng T; Yang D; Chang RC; So KF; Liu K; Shen J
    J Ethnopharmacol; 2013 Oct; 150(1):116-24. PubMed ID: 23973788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose dependence and therapeutic window for the neuroprotective effects of curcumin in thromboembolic model of rat.
    Dohare P; Garg P; Jain V; Nath C; Ray M
    Behav Brain Res; 2008 Nov; 193(2):289-97. PubMed ID: 18611416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective effect of curcumin in middle cerebral artery occlusion induced focal cerebral ischemia in rats.
    Thiyagarajan M; Sharma SS
    Life Sci; 2004 Jan; 74(8):969-85. PubMed ID: 14672754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FeTPPS protects against global cerebral ischemic-reperfusion injury in gerbils.
    Sharma SS; Dhar A; Kaundal RK
    Pharmacol Res; 2007 Apr; 55(4):335-42. PubMed ID: 17292620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sevoflurane preconditioning against focal cerebral ischemia: inhibition of apoptosis in the face of transient improvement of neurological outcome.
    Codaccioni JL; Velly LJ; Moubarik C; Bruder NJ; Pisano PS; Guillet BA
    Anesthesiology; 2009 Jun; 110(6):1271-8. PubMed ID: 19417596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective effect of peroxynitrite decomposition catalyst and poly(adenosine diphosphate-ribose) polymerase inhibitor alone and in combination in rats with focal cerebral ischemia.
    Sharma SS; Munusamy S; Thiyagarajan M; Kaul CL
    J Neurosurg; 2004 Oct; 101(4):669-75. PubMed ID: 15481724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective effect of MnTMPyP, a superoxide dismutase/catalase mimetic in global cerebral ischemia is mediated through reduction of oxidative stress and DNA fragmentation.
    Sharma SS; Gupta S
    Eur J Pharmacol; 2007 Apr; 561(1-3):72-9. PubMed ID: 17320858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Administration of N-acetylcysteine after focal cerebral ischemia protects brain and reduces inflammation in a rat model of experimental stroke.
    Khan M; Sekhon B; Jatana M; Giri S; Gilg AG; Sekhon C; Singh I; Singh AK
    J Neurosci Res; 2004 May; 76(4):519-27. PubMed ID: 15114624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-oxidant activity mediated neuroprotective potential of trimetazidine on focal cerebral ischaemia-reperfusion injury in rats.
    Dhote V; Balaraman R
    Clin Exp Pharmacol Physiol; 2008 May; 35(5-6):630-7. PubMed ID: 18318745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed post ischemic treatment with Rosiglitazone attenuates infarct volume, neurological deficits and neutrophilia after embolic stroke in rat.
    Allahtavakoli M; Moloudi R; Arababadi MK; Shamsizadeh A; Javanmardi K
    Brain Res; 2009 May; 1271():121-7. PubMed ID: 19332033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thalidomide protects against ischemic neuronal damage induced by focal cerebral ischemia in mice.
    Hyakkoku K; Nakajima Y; Izuta H; Shimazawa M; Yamamoto T; Shibata N; Hara H
    Neuroscience; 2009 Mar; 159(2):760-9. PubMed ID: 19166916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Neuroprotection of puerarin against cerebral ischemia is associated with the prevention of apoptosis in rats.
    Xu X; Zhang S; Zhang L; Yan W; Zheng X
    Planta Med; 2005 Jul; 71(7):585-91. PubMed ID: 16041641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurovascular and neuronal protection by E64d after focal cerebral ischemia in rats.
    Tsubokawa T; Yamaguchi-Okada M; Calvert JW; Solaroglu I; Shimamura N; Yata K; Zhang JH
    J Neurosci Res; 2006 Sep; 84(4):832-40. PubMed ID: 16802320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory mechanisms of tetramethylpyrazine in middle cerebral artery occlusion (MCAO)-induced focal cerebral ischemia in rats.
    Hsiao G; Chen YC; Lin JH; Lin KH; Chou DS; Lin CH; Sheu JR
    Planta Med; 2006 Apr; 72(5):411-7. PubMed ID: 16557454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective effect of curcumin on transient focal cerebral ischemia in rats.
    Zhao J; Zhao Y; Zheng W; Lu Y; Feng G; Yu S
    Brain Res; 2008 Sep; 1229():224-32. PubMed ID: 18640105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.